Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare CNS Tumor”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableEnrolling By InvitationNCT06041906
What this trial is testing

International Registry of Congenital Portosystemic Shunt (IRCPSS)

Who this might be right for
Congenital Portosystemic ShuntCPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin 500
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Not applicableEnrolling By InvitationNCT03836300
What this trial is testing

Parent and Infant Inter(X)Action Intervention (PIXI)

Who this might be right for
Fragile X SyndromeAngelman SyndromePrader-Willi Syndrome+11 more
RTI International 120
Testing effectiveness (Phase 2)Study completedNCT00004688
What this trial is testing

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more
Emory University 35
Not applicableStudy completedNCT03251989
What this trial is testing

Rare CNS Tumors Outcomes &Risk

Who this might be right for
High Grade MeningiomaEpendymomaMedulloblastoma+2 more
National Cancer Institute (NCI) 326
Not applicableActive Not RecruitingNCT01623076
What this trial is testing

The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderTransverse Myelitis+1 more
University of Texas Southwestern Medical Center 150
Testing effectiveness (Phase 2)UnknownNCT00004659
What this trial is testing

Phase II Randomized Study of Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone for Multiple Primary or Metastatic Brain Tumors

Who this might be right for
Brain Neoplasms
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing

Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin

Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Large-scale testing (Phase 3)UnknownNCT00004645
What this trial is testing

Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone

Who this might be right for
Acute Disseminated EncephalomyelitisDevic's SyndromeMarburg's Variant of Multiple Sclerosis+2 more
National Institute of Neurological Disorders and Stroke (NINDS) 22
Testing effectiveness (Phase 2)Study completedNCT03012620
What this trial is testing

Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types

Who this might be right for
SarcomaOvarian NeoplasmCentral Nervous System Neoplasm+4 more
UNICANCER 334
Not applicableLooking for participantsNCT06878469
What this trial is testing

SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence

Who this might be right for
Brain Tumors
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02574728
What this trial is testing

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Who this might be right for
Cancer
Emory University 46
Not applicableStudy completedNCT05199402
What this trial is testing

Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases

Who this might be right for
Tuberous SclerosisEpilepsy
Imagine Institute 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05256290
What this trial is testing

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

Who this might be right for
Non-Small Cell Lung CancerAdvanced Non-Small Cell Squamous Lung CancerMetastatic Lung Non-Small Cell Carcinoma+7 more
Black Diamond Therapeutics, Inc. 200
Not applicableStudy completedNCT00001686
What this trial is testing

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Who this might be right for
Ewing's SarcomaLeukemiaLymphoma+2 more
National Cancer Institute (NCI) 482
Not applicableStudy completedNCT05161494
What this trial is testing

Gait in Rare Diseases

Who this might be right for
Tuberous SclerosisSTXBP1 Encephalopathy With Epilepsy
Universiteit Antwerpen 41
Not applicableLooking for participantsNCT04880356
What this trial is testing

Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.

Who this might be right for
Inherited DiseaseRare DiseasesMetabolic Disease+3 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 100
Not applicableLooking for participantsNCT07374692
What this trial is testing

Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors

Who this might be right for
Recurrent CNS TumorsBrain CancerGliomas+3 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02867592
What this trial is testing

Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

Who this might be right for
Adrenal Cortical CarcinomaAlveolar Soft Part SarcomaCentral Nervous System Neoplasm+41 more
National Cancer Institute (NCI) 109
Next Page